One-year direct costs of biological therapy in rheumatoid arthritis and its predictive factors: data from the Moroccan RBSMR registry
S. Fellous(Centre Hospitalier Ibn Sina), F. Allali(Délégation Paris 5), L. Ichchou(Hôpital El Ayachi), L. Achemlal, R. Niamane(Hôpital Militaire Avicenne), Latifa Tahiri, I. Ghozlani(Régie Autonome Multi Services D'Agadir), Samir Ahid(Mohammed V University), H. Hassikou, R. Bahiri(Centre Hospitalier Universitaire de Rabat-Salé), I. El Bouchti, Taoufik Harzy(Hôpital El Ayachi), Hanan Rkain(Hôpital El Ayachi), Rédouane Abouqal(Mohammed V University), O. Mkinsi(Centre Hospitalier Universitaire Ibn Rochd), Ihsane Hmamouchi(International University of Rabat), A. El Maghraoui
Cited by 10
Related Papers
Why we should definitely include intra-articular hyaluronic acid as a therapeutic option in the management of knee osteoarthritis: Results of an extensive critical literature review
|Seminars in Arthritis and Rheumatism|2018|164
High Prevalence of Hypovitaminosis D in Morocco: Relationship to Lifestyle, Physical Performance, Bone Markers, and Bone Mineral Density
|Seminars in Arthritis and Rheumatism|2008|154
Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor α
|Annals of the Rheumatic Diseases|2003|122
Sarcopenia in rheumatoid arthritis: prevalence, influence of disease activity and associated factors
|Rheumatology International|2017|114